Clinical trial · Interventional
Self-sampling Among Long-term Non-attenders to Cervical Cancer Screening
A Pragmatic Randomized Controlled Trial of Self-sampling Among Long-term Non-attenders to Cervical Cancer Screening
NCT03873376CI-TRIAL-00057948completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The trial will evaluate whether human papillomavirus (HPV) self-sampling may increase cervical cancer screening attendance among under-screened women in Norway, how different ways of offering self-sampling and follow-up may affect attendance, and whether self-sampling may reduce inequities in attendance.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cervical Cancer | Malignant Cervical Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Control; Receive open reminder to be screened by physician | Behavioral | — | UNRESOLVED |
| Opt-in; Receive offer to order self-sampling kit | Behavioral | — | UNRESOLVED |
| Opt-out; Receive self-sampling kit unsolicited | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- type
- EXPERIMENTAL
- label
- Opt-in
- description
- Receive offer to order self-sampling kit
- interventionNames
- Behavioral: Opt-in; Receive offer to order self-sampling kit
- type
- EXPERIMENTAL
- label
- Opt-out
- description
- Receive self-sampling kit unsolicited
- interventionNames
- Behavioral: Opt-out; Receive self-sampling kit unsolicited
- type
- EXPERIMENTAL
- label
- Control
- description
- Receive open reminder to be screened by physician
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 35 Years
- Maximum age
- 69 Years
Show eligibility criteria text
Inclusion Criteria: * Women living in the regions Hordaland, Vest-Agder, Rogaland or Sør-Trøndelag, who have been eligible for screening in Norway, but who have not attended screening for at least 10 years (2009-2018) Exclusion Criteria: * Women who have not been eligible for cervical cancer screening during the entire 10 year period (2009-2018)
References
Publications (1)
- DERIVEDAasbo G, Trope A, Nygard M, Christiansen IK, Baasland I, Iversen GA, Munk AC, Christiansen MH, Presthus GK, Undem K, Bjorge T, Castle PE, Hansen BT. HPV self-sampling among long-term non-attenders to cervical cancer screening in Norway: a pragmatic randomised controlled trial. Br J Cancer. 2022 Nov;127(10):1816-1826. doi: 10.1038/s41416-022-01954-9. Epub 2022 Aug 23. PMID 35995936